Product Name

  • Name

    Oxaliplatin

  • EINECS 274-613-9
  • CAS No. 61825-94-3
  • Article Data22
  • CAS DataBase
  • Density
  • Solubility Soluble in water with heating and/or sonication
  • Melting Point
  • Formula C8H14N2O4Pt
  • Boiling Point 193.6oC at 760 mmHg
  • Molecular Weight 397.29
  • Flash Point 75oC
  • Transport Information UN 2811
  • Appearance White crystalline solid
  • Safety 26-36
  • Risk Codes 36/37/38-40-42/43
  • Molecular Structure Molecular Structure of 61825-94-3 (Oxaliplatin)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms Eloxatin;1-OHP;(1R,2R)-cyclohexane-1,2-diamine; oxalic acid; platinum(+2) cation;Eloxatin (TN);Trans-l-diaminocyclohexane oxalatoplatinum;Platinum, (1,2-cyclohexanediamine-N,N)(ethanedioato(2-)-O,O-, (SP-4-2-(1R-trans))-;Platinum, [ (1R,2R)-1,2-cyclohexanediamine-.kappa.N, .kappa.N][ethanedioato(2-)-.kappa.O1,.kappa.O2]-,(SP-4-2)-;(SP-4-2-(1R-trans))-(1,2-Cyclohexanediamine-N,N)(ethanedioato(2-)-O,O)platinum;RP 54780;Oxalatoplatinum;Oxaliplatin EP5;
  • PSA 104.64000
  • LogP 0.61450

Synthetic route

cis-diacetato-trans-l-diaminocyclohexane platinum(II)

cis-diacetato-trans-l-diaminocyclohexane platinum(II)

potassium oxalate
583-52-8

potassium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water at 60 - 70℃; for 5 - 6h; Product distribution / selectivity; Heating / reflux;67%
cis-diacetato-trans-l-1,2-diaminocyclohexane platinum(II)

cis-diacetato-trans-l-1,2-diaminocyclohexane platinum(II)

potassium oxalate
583-52-8

potassium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water for 5 - 6h; Product distribution / selectivity; Heating / reflux;67%
oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
Stage #1: (1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II) With water; silver nitrate at 20 - 45℃; for 2.08333h;
Stage #2: oxalic acid With potassium hydroxide In water at 20℃; for 4h; pH=2.9; Product distribution / selectivity;
62.9%
Stage #1: (1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II) With silver nitrate In water at 20℃; for 70h;
Stage #2: With tetraethylammonium iodide In water for 16h;
Stage #3: oxalic acid In water for 4h;
54%
Stage #1: (1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II) With water; silver nitrate at 20℃; for 70h;
Stage #2: oxalic acid In water at 20℃; for 4h; Product distribution / selectivity;
40.3%
(trans-(R,R)-1,2-diaminocyclohexane)diiodoplatinum(II)

(trans-(R,R)-1,2-diaminocyclohexane)diiodoplatinum(II)

potassium oxalate
583-52-8

potassium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
Stage #1: trans-(R,R)-(1,2-diaminocyclohexane)diiodoplatinum(II) With acetic acid; silver(l) oxide In water at 80 - 90℃; for 4h;
Stage #2: potassium oxalate In water at 60℃; for 5h; Product distribution / selectivity;
60%
(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)
61848-66-6

(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)

bis(tetrabutylammonium)oxalate
33081-83-3

bis(tetrabutylammonium)oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In i-Amyl alcohol; water at 85 - 88℃; for 8 - 10h; Product distribution / selectivity;50%
(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)
61848-66-6

(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)

water
7732-18-5

water

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

C12H28N4O2Pt2

C12H28N4O2Pt2

Conditions
ConditionsYield
Stage #1: (1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II); water With silver nitrate at 20℃; for 48h;
Stage #2: oxalic acid In water at 20℃; for 4h; Product distribution / selectivity;
A 44.1%
B n/a
(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)
61848-66-6

(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)

silver oxalate
15843-43-3, 31038-77-4

silver oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water41%
cis-dichloro-trans-l-1,2-diaminocyclohexane platinum(II)

cis-dichloro-trans-l-1,2-diaminocyclohexane platinum(II)

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With silver(l) oxide In water at 60 - 100℃; for 13 - 14h; Product distribution / selectivity;38%
(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)
61848-66-6

(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With silver(l) oxide In water at 60 - 100℃; for 13 - 14h; Product distribution / selectivity;38%
[Pt((1R,2R)-(-)-1,2-diaminocyclohexane)(H2O)2]SO4

[Pt((1R,2R)-(-)-1,2-diaminocyclohexane)(H2O)2]SO4

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 20h; pH=6;35%
With sodium hydroxide at 20℃; for 20h; pH=6;33%
cis-diiodo-trans-l-1,2-diaminocyclohexane platinum(II)

cis-diiodo-trans-l-1,2-diaminocyclohexane platinum(II)

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With silver(l) oxide In water at 90 - 100℃; for 10 - 12h; Product distribution / selectivity;30%
(trans-(R,R)-1,2-diaminocyclohexane)diiodoplatinum(II)

(trans-(R,R)-1,2-diaminocyclohexane)diiodoplatinum(II)

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With silver(l) oxide In water at 90 - 100℃; for 10 - 12h; Product distribution / selectivity;30%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

oxalic acid
144-62-7

oxalic acid

trans-1,2-cyclohexanediamine

trans-1,2-cyclohexanediamine

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With potassium iodide; silver(l) oxide In water at 90 - 100℃; for 10 - 12h; Product distribution / selectivity;20%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

(1R,2R)-1,2-diaminocyclohexane
20439-47-8

(1R,2R)-1,2-diaminocyclohexane

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With silver(l) oxide In water at 90 - 100℃; for 10 - 12h;20%
potassium platinum(II) oxalate

potassium platinum(II) oxalate

trans-1,2-cyclohexanediamine

trans-1,2-cyclohexanediamine

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With acetic acid In water at 90℃; for 6h; pH=6.6 - 7.5; Product distribution / selectivity;15%
In water; acetone at 95℃; for 1.5h; Product distribution / selectivity;15%
cis-bis(methanesulphonato)-trans-l-1,2-diaminocyclohexane platinum(II)

cis-bis(methanesulphonato)-trans-l-1,2-diaminocyclohexane platinum(II)

potassium oxalate
583-52-8

potassium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water for 6h; Product distribution / selectivity; Heating / reflux;
C6H18N2O2Pt(2+)*2NO3(1-)

C6H18N2O2Pt(2+)*2NO3(1-)

ammonium oxalate
1113-38-8

ammonium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water at 45℃; for 8h;
2CH3O3S(1-)*C6H18N2O2Pt(2+)

2CH3O3S(1-)*C6H18N2O2Pt(2+)

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
Product distribution / selectivity;
[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

oxalic acid
144-62-7

oxalic acid

oxaliplatin
61825-94-3

oxaliplatin

C12H28N4O2Pt2

C12H28N4O2Pt2

Conditions
ConditionsYield
In water at 20℃; for 4h; Product distribution / selectivity;
(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)
61848-66-6

(1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II)

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
purifn. by HPLC; elem.anal.;;
platinum(IV)Cl2 oxalate (1R, 2R-cyclohexandiamine)

platinum(IV)Cl2 oxalate (1R, 2R-cyclohexandiamine)

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water at room temp. in sunlight; chromy.; UV;
With ascorbic acid In water at room temp. in the dark; chromy.; UV;
[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

sodium oxalate
62-76-0

sodium oxalate

oxaliplatin
61825-94-3

oxaliplatin

C12H28N4O2Pt2

C12H28N4O2Pt2

Conditions
ConditionsYield
at 20℃; for 2 - 4h; pH=12; Product distribution / selectivity; Absence of light;
[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

[Pt(OH)2(trans-(1R,2R)-diaminocyclohexane)]

oxaliplatin
61825-94-3

oxaliplatin

C12H28N4O2Pt2

C12H28N4O2Pt2

Conditions
ConditionsYield
With oxalic acid In water for 4h; Product distribution / selectivity;
cis-bismethanesulphonato-trans-l-1,2-diaminocyclohexane platinum(II)

cis-bismethanesulphonato-trans-l-1,2-diaminocyclohexane platinum(II)

potassium oxalate
583-52-8

potassium oxalate

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In water for 6h; Product distribution / selectivity; Heating / reflux;
bis(3-carboxypropanoato)(trans-1R,2R-diaminocyclohexane)oxalatoplatinum(IV)

bis(3-carboxypropanoato)(trans-1R,2R-diaminocyclohexane)oxalatoplatinum(IV)

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
In aq. phosphate buffer pH=7; Electrochemical reaction;
C76H124N6O14Pt

C76H124N6O14Pt

oxaliplatin
61825-94-3

oxaliplatin

B

C34H56N2O5
1239481-01-6

C34H56N2O5

Conditions
ConditionsYield
With sodium L-ascorbate In water
C15H26N2O8Pt

C15H26N2O8Pt

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With C49H42N7Ru(3+)*3F6P(1-); water-d2 for 1h; Irradiation;
phorbiplatin

phorbiplatin

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With sodium L-ascorbate In N,N-dimethyl-formamide; acetonitrile for 0.166667h; pH=7.4; Mechanism; Irradiation;
C43H50N6O9Pt

C43H50N6O9Pt

oxaliplatin
61825-94-3

oxaliplatin

B

pyropheophorbide a acid

pyropheophorbide a acid

Conditions
ConditionsYield
With sodium L-ascorbate In N,N-dimethyl-formamide for 0.166667h; pH=7.4; Mechanism; Irradiation;
t-[Pt(DACH)(ox)(OOCCH2CH2CH2CH2CH2CH2CH3)(OOCCH3)]

t-[Pt(DACH)(ox)(OOCCH2CH2CH2CH2CH2CH2CH3)(OOCCH3)]

oxaliplatin
61825-94-3

oxaliplatin

Conditions
ConditionsYield
With sodium L-ascorbate In aq. phosphate buffer at 37℃; under 760.051 Torr; pH=7.4; Kinetics; Darkness;
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

[Pt(1,2-diaminocyclohexane)(OH)2(ox)]

[Pt(1,2-diaminocyclohexane)(OH)2(ox)]

Conditions
ConditionsYield
for 12h;94%
oxaliplatin
61825-94-3

oxaliplatin

ethanol
64-17-5

ethanol

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

c,c,t-(1R,2R-diaminocyclohexane)oxalatoethoxidohydroxoplatinum(IV)

c,c,t-(1R,2R-diaminocyclohexane)oxalatoethoxidohydroxoplatinum(IV)

Conditions
ConditionsYield
In water at 70℃; for 5h;92%
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

[(1R,2R)-cyclohexane-1,2-diamine-N,N']dihydroxidooxalato-platinum(IV),trans-[Pt(OH)2(ox)(R,R-chxn)]

[(1R,2R)-cyclohexane-1,2-diamine-N,N']dihydroxidooxalato-platinum(IV),trans-[Pt(OH)2(ox)(R,R-chxn)]

Conditions
ConditionsYield
In water at 50℃; for 1h;90%
In water at 20℃; for 24h; Darkness;89%
In water at 70℃; for 5h;80.6%
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

Conditions
ConditionsYield
In water at 50℃; for 5h; Darkness;90%
In water at 60 - 65℃; Darkness;74%
In water at 60℃; for 4h;71%
oxaliplatin
61825-94-3

oxaliplatin

water
7732-18-5

water

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

[(1R,2R)-cyclohexane-1,2-diamine-N,N']dihydroxidooxalato-platinum(IV),trans-[Pt(OH)2(ox)(R,R-chxn)]

[(1R,2R)-cyclohexane-1,2-diamine-N,N']dihydroxidooxalato-platinum(IV),trans-[Pt(OH)2(ox)(R,R-chxn)]

Conditions
ConditionsYield
at 50℃; for 1h;90%
oxaliplatin
61825-94-3

oxaliplatin

N-chloro-succinimide
128-09-6

N-chloro-succinimide

water
7732-18-5

water

hydroxychlorooxaliplatin(IV)

hydroxychlorooxaliplatin(IV)

Conditions
ConditionsYield
at 20℃; for 3h; Darkness;89.3%
at 20℃; Inert atmosphere;89.2%
at 60℃; Darkness;89%
oxaliplatin
61825-94-3

oxaliplatin

N-chloro-succinimide
128-09-6

N-chloro-succinimide

trans-Pt(IV)Cl2(oxalato)(l-1,2-cyclohexanediamine)

trans-Pt(IV)Cl2(oxalato)(l-1,2-cyclohexanediamine)

Conditions
ConditionsYield
In ethanol for 8h; Darkness; Reflux;89%
oxaliplatin
61825-94-3

oxaliplatin

N-iodo-succinimide
516-12-1

N-iodo-succinimide

trans-[Pt(trans-(1R, 2R)-1,2-cyclohexanediammine)(oxalate)(C4H4NO2)l]

trans-[Pt(trans-(1R, 2R)-1,2-cyclohexanediammine)(oxalate)(C4H4NO2)l]

Conditions
ConditionsYield
In ethanol at 20℃; for 8h; Darkness;84%
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

bromoacetic acid
79-08-3

bromoacetic acid

2-bromoaceto-[(1R,2R)-cyclohexane-1,2-diamine-N,N']hydroxidooxalatoplatinum(IV)

2-bromoaceto-[(1R,2R)-cyclohexane-1,2-diamine-N,N']hydroxidooxalatoplatinum(IV)

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 1h;83%
oxaliplatin
61825-94-3

oxaliplatin

N-Bromosuccinimide
128-08-5

N-Bromosuccinimide

water
7732-18-5

water

trans-[Pt(trans-(1R,2R)-1,2-cyclohexanediammine)(oxalate)(OH)Br]

trans-[Pt(trans-(1R,2R)-1,2-cyclohexanediammine)(oxalate)(OH)Br]

Conditions
ConditionsYield
at 20℃; for 12h;81%
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

cis-oxalic acid (trans-1,2-cyclohexanediamine)dihydroxyplatinum(II)
111263-58-2, 111321-67-6, 111321-78-9, 198292-19-2

cis-oxalic acid (trans-1,2-cyclohexanediamine)dihydroxyplatinum(II)

Conditions
ConditionsYield
at 50℃;81%
succinic acid anhydride
108-30-5

succinic acid anhydride

oxaliplatin
61825-94-3

oxaliplatin

C16H24N2O12Pt

C16H24N2O12Pt

Conditions
ConditionsYield
Stage #1: oxaliplatin With dihydrogen peroxide In water at 20 - 50℃; for 27h; Darkness;
Stage #2: succinic acid anhydride In N,N-dimethyl-formamide at 50℃; for 24h; Darkness;
80%
oxaliplatin
61825-94-3

oxaliplatin

propionic acid anhydride
123-62-6

propionic acid anhydride

C15H26N2O8Pt

C15H26N2O8Pt

Conditions
ConditionsYield
Stage #1: oxaliplatin With dihydrogen peroxide In water at 20 - 50℃; for 27h;
Stage #2: propionic acid anhydride In N,N-dimethyl-formamide at 50℃; for 20h; Darkness;
80%
oxaliplatin
61825-94-3

oxaliplatin

water
7732-18-5

water

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

Conditions
ConditionsYield
at 60℃; for 4h;78%
at 60℃; for 4h;76%
at 40℃; for 18h;
succinic acid anhydride
108-30-5

succinic acid anhydride

oxaliplatin
61825-94-3

oxaliplatin

C14H22N2O10Pt

C14H22N2O10Pt

Conditions
ConditionsYield
Stage #1: oxaliplatin With dihydrogen peroxide; acetic acid at 20℃; for 24h; Darkness;
Stage #2: succinic acid anhydride In N,N-dimethyl-formamide at 50℃; for 24h; Darkness;
76%
oxaliplatin
61825-94-3

oxaliplatin

Nitrogen dioxide
10102-44-0

Nitrogen dioxide

sodium chloride
7647-14-5

sodium chloride

(trans-l-1,2-diaminocyclohexane)oxalatochloronitroplatinum(IV)

(trans-l-1,2-diaminocyclohexane)oxalatochloronitroplatinum(IV)

Conditions
ConditionsYield
In water; acetone at 20℃; for 11.25h;75%
oxaliplatin
61825-94-3

oxaliplatin

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

acetic acid
64-19-7

acetic acid

(OC-6-44)-acetato[(1R,2R)-cyclohexane-1,2-diamine]hydroxidooxalatoplatinum(IV)

(OC-6-44)-acetato[(1R,2R)-cyclohexane-1,2-diamine]hydroxidooxalatoplatinum(IV)

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 48h; Darkness;75%
In water at 20℃; for 19h; Darkness;
oxaliplatin
61825-94-3

oxaliplatin

Nitrogen dioxide
10102-44-0

Nitrogen dioxide

sodium bromide
7647-15-6

sodium bromide

(trans-l-1,2-diaminocyclohexane)oxalatobromonitroplatinum(IV)

(trans-l-1,2-diaminocyclohexane)oxalatobromonitroplatinum(IV)

Conditions
ConditionsYield
In water; acetone at 20℃; for 18.7833h;74%
oxaliplatin
61825-94-3

oxaliplatin

N-Bromosuccinimide
128-08-5

N-Bromosuccinimide

trans-[Pt(trans-(1R,2R)-1,2-cyclohexanediammine)(oxalate)Br2]

trans-[Pt(trans-(1R,2R)-1,2-cyclohexanediammine)(oxalate)Br2]

Conditions
ConditionsYield
In ethanol at 20℃; for 12h;71%
peracetic acid
79-21-0

peracetic acid

oxaliplatin
61825-94-3

oxaliplatin

(OC-6-44)-acetato[(1R,2R)-cyclohexane-1,2-diamine]hydroxidooxalatoplatinum(IV)

(OC-6-44)-acetato[(1R,2R)-cyclohexane-1,2-diamine]hydroxidooxalatoplatinum(IV)

Conditions
ConditionsYield
With acetic acid for 24.5h;66%
oxaliplatin
61825-94-3

oxaliplatin

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

(SP-4-2)-(trans-R,R-cyclohexane-1,2-diamine)dihydroxo(oxalato) platinum(IV)

Conditions
ConditionsYield
With dihydrogen peroxide In water at 50℃; for 3h; Inert atmosphere;64.3%
With dihydrogen peroxide In water at 30℃; for 12h; Darkness;
With dihydrogen peroxide In water at 60 - 70℃; for 4h; Inert atmosphere;
oxaliplatin
61825-94-3

oxaliplatin

bromoacetic acid
79-08-3

bromoacetic acid

di-2-bromoacetato[(1R,2R)-cyclohexane-1,2-diamine-N,N']oxalatoplatinum(IV)

di-2-bromoacetato[(1R,2R)-cyclohexane-1,2-diamine-N,N']oxalatoplatinum(IV)

Conditions
ConditionsYield
With dihydrogen peroxide In tetrahydrofuran at 20℃; for 24h;53%

Oxaliplatin Chemical Properties

Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin.  Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility.
Product Name: Oxaliplatin (CAS NO.61825-94-3)

Molecular Formula: C8H14N2O4Pt
Molecular Weight: 397.29g/mol
Mol File: 61825-94-3.mol
Appearance: White Crystalline Solid
Boiling point: 193.6 °C at 760 mmHg
Flash Point: 75 °C
Stability: Stable. Store cool. Incompatible with oxidizing agents.
Enthalpy of Vaporization: 42.98 kJ/mol
Vapour Pressure: 0.46 mmHg at 25°C
H-Bond Donor: 2
H-Bond Acceptor: 6
Structure Descriptors of Oxaliplatin (CAS NO.61825-94-3):
  IUPAC Name: (1R,2R)-cyclohexane-1,2-diamine; oxalate; platinum(4+)
  Canonical SMILES: C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+4]
  Isomeric SMILES: C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+4]
  InChI: InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+4/p-2/t5-,6-;;/m1../s1 
  InChIKey: PCRKGXHIGVOZKB-BNTLRKBRSA-L
Product Categories: Pharmaceutical material and intermeidates; Active Pharmaceutical Ingredients; Antineoplastic; Intermediates & Fine Chemicals; Pharmaceuticals

Oxaliplatin History

Oxaliplatin was discovered in 1976 at Nagoya City University in Japan by Professor Yoshinori Kidani, who was granted U.S. Patent 4,169,846 over the drug in 1979. Oxaliplatin was subsequently in-licensed by Debiopharm, a Swiss drug company headquartered in Lausanne and developed as an advanced colorectal cancer treatment. Debio licensed the drug to Sanofi-Aventis in 1994. Eloxatin gained European approval in 1996 (firstly in France) and approval by the U.S. Food and Drug Administration (FDA) in 2002.

Oxaliplatin Uses

It is typically administered in combination with fluorouracil and leucovorin in a combination known as FOLFOX for the treatment of colorectal cancer.

Oxaliplatin Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 19800ug/kg (19.8mg/kg)   Drugs of the Future. Vol. 14, Pg. 529, 1989.
rat LD50 intraperitoneal 14300ug/kg (14.3mg/kg)   Drugs of the Future. Vol. 14, Pg. 529, 1989.

Oxaliplatin Safety Profile

Safety Information of Oxaliplatin (CAS NO.61825-94-3):
Hazard Codes: XnHarmful,XiIrritant
Risk Statements: 36/37/38-40-42/43  
R36/37/38:Irritating to eyes, respiratory system and skin. 
R40:Limited evidence of a carcinogenic effect. 
R42/43:May cause sensitization by inhalation and skin contact.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing.
RIDADR: 2811
WGK Germany: 3
RTECS: TP2275850
HazardClass: 6.1(a)
PackingGroup: II

Oxaliplatin Specification

 Oxaliplatin , its CAS NO. is 61825-94-3, the synonyms are (SP-4-2-(1R-trans))-(1,2-Cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')platinum ; Dacplat ; Eloxatin ; Elplat ; JM-83 ; Lipoxal ; Oxalato(1R,2R-cyclohexanediammine)platinum(II) ; Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II) ; Oxalato(trans-1-1,2-cyclohexanediamine)platinum(II) ; Oxalatoplatinum ; UNII-04ZR38536J ; cis-((1R,2R)-1,2-Cyclohexanediamine-N,N')(oxalato(2-)-O,O')platinum ; trans-l-Diaminocyclohexane oxalatoplatinum ; Platinum, ((1R,2R)-1,2-cyclohexanediamine-.kappa.N,.kappa.N')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2)- ; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(1R-trans))- .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View